Thieme to distribute Manson titles in the US

Share this article:
Thieme to distribute Manson titles in the US
Thieme to distribute Manson titles in the US

Thieme Publishers will distribute UK-based Manson Publishing titles in the Americas and India, a portfolio that includes close to 100 medical and veterinary titles.

The deal is a good match for both publishers, said Thieme sales director Ross Lumpkin, since both are “very visual publishers.” Manson's self-assessment color review series, “the best color Q&A prep for the [medical] boards,” per Lumpkin, and its color handbook series focused on specific topics like heart failure and gastroenterology, are both popular offerings for physicians and students, he said.

Several new Manson titles will be launched in the coming months: Parkinson's Disease, Child Abuse and Neglect – A Diagnostic Guide, and Psoriasis, to name three, and other new titles will be announced quarterly. A release on the deal describes Manson's approach as “having leading authors – mainly from the US and Europe – create concise text/reference books for professionals and students in medicine and veterinary medicine,” illustrated with photographs and diagrams.

Camille Beck, a spokesperson for Thieme, said the Manson titles do not contain advertising “at this time,” but special run printing is available. “It used to be that a [pharmaceutical] company would have to commit to taking at least 500 books to make a special printing with their logo on the cover and a message to the reader inside,” said Lumpkin, adding that marketers can go as low as 100 copies now. “The major stumbling block is that the pharmaceutical company is in too big a rush, and can't wait for what could take two-to-three months to deliver, so they settle for placing a logo sticker on the cover and inserting a message.”

In the past, Manson titles have been distributed in North America under the imprints of various US publishers. Thieme publishes over 130 peer-reviewed medical and scientific journals (in English and German), as well as 70 new book titles each year, according to the company website. Although Thieme provides online journal access to print subscribers, the company does not offer online-exclusive subscriptions, and does not publish any digital-only journals. However, Thieme “hopes to change this in the near future,” according to Beck.   

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...